These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 36740524)

  • 41. Reimbursement for pharmacist-provided health care services: A multistate review.
    Nguyen E; Walker K; Adams JL; Wadsworth T; Robinson R
    J Am Pharm Assoc (2003); 2021; 61(1):27-32. PubMed ID: 33069593
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The pharmacist as physician extender in family medicine office practice.
    Nichol A; Downs GE
    J Am Pharm Assoc (2003); 2006; 46(1):77-83. PubMed ID: 16529343
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Outcomes-based pharmacist reimbursement: reimbursing pharmacists for cognitive services part 1.
    Farris KB; Kumbera P; Halterman T; Fang G
    J Manag Care Pharm; 2002; 8(5):383-93. PubMed ID: 14613406
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of Pharmacists' Work in a Physician-Pharmacist Collaborative Model for the Management of Hypertension.
    Isetts BJ; Buffington DE; Carter BL; Smith M; Polgreen LA; James PA
    Pharmacotherapy; 2016 Apr; 36(4):374-84. PubMed ID: 26893135
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Assessing the Effect of Pharmacist Care on Diabetes-Related Outcomes in a Rural Outpatient Clinic: A Retrospective Case-Control Study.
    Moreau C; Sando KR; Zambrano DH
    Ann Pharmacother; 2017 Jun; 51(6):473-478. PubMed ID: 28064508
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Implementation of an older adult epilepsy clinic utilizing pharmacist services.
    Marawar R; Faraj M; Lucas K; Burns CV; Garwood CL
    J Am Pharm Assoc (2003); 2021; 61(6):e93-e98. PubMed ID: 34330650
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of an ambulatory care pharmacist on provider relative value units in a rural clinic.
    DeRemer CE; Perez NA; Middleton K; Konopack J; Dietrich E
    Explor Res Clin Soc Pharm; 2022 Mar; 5():100098. PubMed ID: 35478518
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of an ambulatory care pharmacist in an occupational health clinic.
    Parsons KA; Zimmermann AE
    J Am Pharm Assoc (2003); 2019; 59(1):64-69.e1. PubMed ID: 30396761
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacoeconomic, Medication Access, and Patient-Satisfaction Analysis of a Pharmacist-Managed VTE Clinic Compared to Primary Care Physician Outpatient Therapy.
    Howell CW; Walroth TA; Beam DM; Geik CA; Howell MM; Macik MR; Schmelz AN; DiRenzo BM
    J Pharm Pract; 2022 Apr; 35(2):212-217. PubMed ID: 35484867
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Medicaid reimbursement for pharmacist services: A strategy for the pharmacy profession.
    Schweitzer P; Atalla M
    Am J Health Syst Pharm; 2021 Feb; 78(5):408-415. PubMed ID: 33605989
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oncology Pharmacist Opportunities: Closing the Gap in Quality Care.
    Vulaj V; Hough S; Bedard L; Farris K; Mackler E
    J Oncol Pract; 2018 Jun; 14(6):e403-e411. PubMed ID: 29298114
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacist implementation of a transitions of care electronic referral process to provide hand-off between inpatient and outpatient settings.
    Martirosov AL; Seitllari K; Kaurala S; MacDonald N
    J Am Pharm Assoc (2003); 2020; 60(1):112-116.e1. PubMed ID: 31690512
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cost-Effectiveness Analysis of a Pharmacist-Led Medication Therapy Management Program: Hypertension Management.
    Schultz BG; Tilton J; Jun J; Scott-Horton T; Quach D; Touchette DR
    Value Health; 2021 Apr; 24(4):522-529. PubMed ID: 33840430
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Consumer, physician, and payer perspectives on primary care medication management services with a shared resource pharmacists network.
    Smith M; Cannon-Breland ML; Spiggle S
    Res Social Adm Pharm; 2014; 10(3):539-53. PubMed ID: 24055137
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Payers' Perspectives on Pharmacist-Directed Care in a Community Pharmacy Setting.
    Merrill BS; Tak CR; Feehan M; Munger MA
    Ann Pharmacother; 2019 Sep; 53(9):916-921. PubMed ID: 30895798
    [No Abstract]   [Full Text] [Related]  

  • 56. Quality of Pharmacist-Managed Anticoagulation Therapy in Long-Term Ambulatory Settings: A Systematic Review.
    Manzoor BS; Cheng WH; Lee JC; Uppuluri EM; Nutescu EA
    Ann Pharmacother; 2017 Dec; 51(12):1122-1137. PubMed ID: 28735551
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Improving clinical documentation of evaluation and management care and patient acuity improves reimbursement as well as quality metrics.
    Seligson MT; Lyden SP; Caputo FJ; Kirksey L; Rowse JW; Smolock CJ
    J Vasc Surg; 2021 Dec; 74(6):2055-2062. PubMed ID: 34186163
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacist impact on medication dosing and billable coding accuracy in outpatients with chronic kidney disease.
    Cypes IN; Prohaska ES; Melton BL
    J Am Pharm Assoc (2003); 2021; 61(2):e153-e158. PubMed ID: 33160871
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Formation of a primary care pharmacist practice-based research network.
    Dickerson LM; Kraus C; Kuo GM; Weber CA; Bazaldua OV; Tovar JM; Hume AL; Ives TJ; Gums JG; Carter BL
    Am J Health Syst Pharm; 2007 Oct; 64(19):2044-9. PubMed ID: 17893415
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.